Nanotechnology for the Detection and Therapy of Stroke

Over the years, nanotechnology has greatly developed, moving from careful design strategies and synthesis of novel nanostructures to producing them for specific medical and biological applications. The use of nanotechnology in diagnostics, drug delivery, and tissue engineering holds great promise for the treatment of stroke in the future. Nanoparticles are employed to monitor grafted cells upon implantation, or to enhance the imagery of the tissue, which is coupled with a noninvasive imaging modality such as magnetic resonance imaging, computed axial tomography or positron emission tomography scan. Contrast imaging agents used can range from iron oxide, perfluorocarbon, cerium oxide or platinum nanoparticles to quantum dots. The use of nanomaterial scaffolds for neuroregeneration is another area of nanomedicine, which involves the creation of an extracellular matrix mimic that not only serves as a structural support but promotes neuronal growth, inhibits glial differentiation, and controls hemostasis. Promisingly, carbon nanotubes can act as scaffolds for stem cell therapy and functionalizing these scaffolds may enhance their therapeutic potential for treatment of stroke. This Progress Report highlights the recent developments in nanotechnology for the detection and therapy of stroke. Recent advances in the use of nanomaterials as tissue engineering scaffolds for neuroregeneration will also be discussed.

[1]  J. Jansen,et al.  The use of micro- and nanospheres as functional components for bone tissue regeneration. , 2012, Tissue engineering. Part B, Reviews.

[2]  D. S. Lee,et al.  The use of pH-sensitive positively charged polymeric micelles for protein delivery. , 2012, Biomaterials.

[3]  Z. Fei,et al.  Up-regulation of Heme oxygenase-1 attenuates brain damage after cerebral ischemia via simultaneous inhibition of superoxide production and preservation of NO bioavailability , 2013, Experimental Neurology.

[4]  Donald R McCrimmon,et al.  Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. , 2010, Nano letters.

[5]  Drug targeting to the brain. , 2007, Annual review of pharmacology and toxicology.

[6]  Sabina Passamonti,et al.  Hemolytic effects of water-soluble fullerene derivatives. , 2004, Journal of medicinal chemistry.

[7]  Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. , 2009, JACC. Cardiovascular interventions.

[8]  Vasilis Ntziachristos,et al.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging , 2010, Particle and Fibre Toxicology.

[9]  J. Provenzale,et al.  Uses of Nanoparticles for Central Nervous System Imaging and Therapy , 2009, American Journal of Neuroradiology.

[10]  M. Guanci,et al.  Acute Ischemic Stroke Review , 2007, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[11]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[12]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Jean-Christophe Olivier,et al.  Drug transport to brain with targeted nanoparticles , 2011, NeuroRX.

[14]  N. Manabe,et al.  Quantum Dot as a Drug Tracer In Vivo , 2006, IEEE Transactions on NanoBioscience.

[15]  J. Grotta,et al.  Therapeutic Time Window and Dose Dependence of Xenon Delivered via Echogenic Liposomes for Neuroprotection in Stroke , 2013, CNS neuroscience & therapeutics.

[16]  Duccio Cavalieri,et al.  Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. , 2013, Nano letters.

[17]  C. Stremnitzer,et al.  Interleukin-10: An Anti-Inflammatory Marker To Target Atherosclerotic Lesions via PEGylated Liposomes , 2012, Molecular pharmaceutics.

[18]  M. Apuzzo,et al.  Visualizing the future: enhancing neuroimaging with nanotechnology. , 2011, World neurosurgery.

[19]  K. Al‐Jamal,et al.  Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[20]  E. Vicaut,et al.  Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials , 2007, Lancet Neurology.

[21]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[22]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[23]  Minhyung Lee,et al.  Amphiphilic peptides with arginines and valines for the delivery of plasmid DNA , 2011, Journal of cellular biochemistry.

[24]  A. Rich,et al.  Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Catafau,et al.  Brain SPECT in clinical practice. Part I: perfusion. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  Minhyung Lee,et al.  Dexamethasone-loaded peptide micelles for delivery of the heme oxygenase-1 gene to ischemic brain. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Jain Kk Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003 .

[28]  T. Webster,et al.  Nanotechnology and nanomaterials: Promises for improved tissue regeneration , 2009 .

[29]  P. Cullis,et al.  Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. , 1998, Advanced drug delivery reviews.

[30]  U. Dirnagl,et al.  Acute pathophysiological processes after ischaemic and traumatic brain injury. , 2010, Best practice & research. Clinical anaesthesiology.

[31]  Jun Li,et al.  High efficient electrical stimulation of hippocampal slices with vertically aligned carbon nanofiber microbrush array , 2009, Biomedical microdevices.

[32]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[33]  S. Andreescu,et al.  Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. , 2011, Free radical biology & medicine.

[34]  Nicholas A Kotov,et al.  Electrical stimulation of neural stem cells mediated by humanized carbon nanotube composite made with extracellular matrix protein. , 2009, Nano letters.

[35]  Gregory W Albers,et al.  Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial , 2012, The Lancet.

[36]  Francesca Ungaro,et al.  Controlled drug delivery in tissue engineering. , 2008, Advanced drug delivery reviews.

[37]  William D Rooney,et al.  Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[39]  Wei Xu,et al.  Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs , 2013, Journal of drug delivery.

[40]  H. Seton,et al.  Magnetic CoPt nanoparticles as MRI contrast agent for transplanted neural stem cells detection. , 2011, Nanoscale.

[41]  M. Abdelhalim The effects of size and period of administration of gold nanoparticles on rheological parameters of blood plasma of rats over a wide range of shear rates: In vivo , 2011, Lipids in Health and Disease.

[42]  Samuel I Stupp,et al.  Heparin binding nanostructures to promote growth of blood vessels. , 2006, Nano letters.

[43]  X. Wu,et al.  Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.

[44]  T. Porter,et al.  Ultrasound, microbubbles, and thrombolysis. , 2001, Progress in cardiovascular diseases.

[45]  M. McPherson,et al.  Recombinant self-assembling peptides as biomaterials for tissue engineering , 2010, Biomaterials.

[46]  N. Kotov,et al.  Successful differentiation of mouse neural stem cells on layer-by-layer assembled single-walled carbon nanotube composite. , 2007, Nano letters.

[47]  S. Caruthers,et al.  Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3‐integrin‐targeted nanoparticles , 2010, Magnetic resonance in medicine.

[48]  Mauro Ferrari,et al.  Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. , 2010, Trends in pharmacological sciences.

[49]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[50]  H. Kusuhara,et al.  Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1). , 2001, Drug discovery today.

[51]  S. Hunt,et al.  Inhibition of inflammation and hyperalgesia in NK-1 receptor knock-out mice , 2003, Neuroreport.

[52]  Ji‐Xin Cheng,et al.  Nanomedicine for treating spinal cord injury. , 2013, Nanoscale.

[53]  U. Dirnagl,et al.  Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like Immunostimulation , 2003, The Journal of experimental medicine.

[54]  Xinmai Yang,et al.  Molecular photoacoustic tomography with colloidal nanobeacons. , 2009, Angewandte Chemie.

[55]  K. Abe,et al.  Neurological and pathological improvements of cerebral infarction in mice with platinum nanoparticles , 2011, Journal of neuroscience research.

[56]  S. Feng,et al.  Multimodal imaging for cancer detection. , 2010, Nanomedicine.

[57]  Shuguang Zhang,et al.  Emerging biological materials through molecular self-assembly. , 2002, Biotechnology advances.

[58]  S. Bhatia,et al.  Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.

[59]  M. Prato,et al.  Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing , 2011, Proceedings of the National Academy of Sciences.

[60]  M. Bryszewska,et al.  Influence of PAMAM dendrimers on human red blood cells. , 2004, Bioelectrochemistry.

[61]  K. Abe,et al.  Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice , 2012, Neuroscience.

[62]  I. Macrae,et al.  Influence of Ischemia and Reperfusion on the Course of Brain Tissue Swelling and Blood–Brain Barrier Permeability in a Rodent Model of Transient Focal Cerebral Ischemia , 1997, Experimental Neurology.

[63]  S. Yusuf,et al.  The HOPE study and diabetes , 2000, The Lancet.

[64]  Richard T. Lee,et al.  Self-assembling short oligopeptides and the promotion of angiogenesis. , 2005, Biomaterials.

[65]  Steven C Kazmierczak,et al.  From diagnostics to therapy: prospects of quantum dots. , 2007, Clinical biochemistry.

[66]  S. Stupp,et al.  Tuning supramolecular mechanics to guide neuron development. , 2013, Biomaterials.

[67]  M. Bally,et al.  Liposomal drug delivery: recent patents and emerging opportunities. , 2007, Recent patents on drug delivery & formulation.

[68]  Zahi A Fayad,et al.  Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.

[69]  Dzmitry G. Shcharbin,et al.  Nanomaterials in stroke treatment: perspectives. , 2013, Stroke.

[70]  Zahi A Fayad,et al.  Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.

[71]  Young Ha Kim,et al.  Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier. , 2013, Biomaterials.

[72]  Neil Desai,et al.  Challenges in Development of Nanoparticle-Based Therapeutics , 2012, The AAPS Journal.

[73]  Garry E. Kiefer,et al.  Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .

[74]  Rohit Bakshi,et al.  Neuroimaging of Stroke: A Review , 2003, Southern medical journal.

[75]  K. Aoshiba,et al.  Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke. , 2009, Pulmonary pharmacology & therapeutics.

[76]  Eileen Ingham,et al.  Production of self-assembling biomaterials for tissue engineering , 2009, Trends in biotechnology.

[77]  Tsong-Hai Lee,et al.  Dexamethasone enhances upregulation of nerve growth factor mRNA expression in ischemic rat brain , 2005, Journal of Clinical Neuroscience.

[78]  Byung-Soo Kim,et al.  Stem cell recruitment and angiogenesis of neuropeptide substance P coupled with self-assembling peptide nanofiber in a mouse hind limb ischemia model. , 2013, Biomaterials.

[79]  R. Simon,et al.  Induction of Caspase-3-Like Protease May Mediate Delayed Neuronal Death in the Hippocampus after Transient Cerebral Ischemia , 1998, The Journal of Neuroscience.

[80]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[81]  Jack Price,et al.  The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. , 2009, Biomaterials.

[82]  Vladimir P Torchilin,et al.  PEG-based micelles as carriers of contrast agents for different imaging modalities. , 2002, Advanced drug delivery reviews.

[83]  C Warlow,et al.  Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. , 2000, Stroke.

[84]  D. Clement A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[85]  C. Antoniades,et al.  Nanomedicine for the prevention, treatment and imaging of atherosclerosis. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[86]  W. Banks,et al.  Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo. , 2013, Molecular pharmaceutics.

[87]  M. Meyyappan,et al.  Vertically Aligned Carbon Nanofiber Architecture as a Multifunctional 3-D Neural Electrical Interface , 2007, IEEE Transactions on Biomedical Engineering.

[88]  Kosuke Hamaguchi,et al.  Intracellular Neural Recording with Pure Carbon Nanotube Probes , 2013, PloS one.

[89]  H. Hong,et al.  A new paradigm for stem cell therapy: Substance-P as a stem cell-stimulating agent , 2011, Archives of pharmacal research.

[90]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[91]  I. Tamai,et al.  Transporter-mediated permeation of drugs across the blood-brain barrier. , 2000, Journal of pharmaceutical sciences.

[92]  Marina A Dobrovolskaia,et al.  Nanoparticles and the immune system. , 2010, Endocrinology.

[93]  Jan P Stegemann,et al.  Carbon nanotubes in neural interfacing applications , 2011, Journal of neural engineering.

[94]  John H. Zhang,et al.  Early inhibition of HIF-1α with small interfering RNA reduces ischemic–reperfused brain injury in rats , 2009, Neurobiology of Disease.

[95]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[96]  Samuel A. Wickline,et al.  Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .

[97]  S. M. Robinson,et al.  Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. , 2005, Bioconjugate chemistry.

[98]  Shelton D Caruthers,et al.  In Vitro Demonstration Using 19F Magnetic Resonance to Augment Molecular Imaging With Paramagnetic Perfluorocarbon Nanoparticles at 1.5 Tesla , 2006, Investigative radiology.

[99]  Juewon Kim,et al.  The effect of TAT conjugated platinum nanoparticles on lifespan in a nematode Caenorhabditis elegans model. , 2010, Biomaterials.

[100]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[101]  Saber M Hussain,et al.  The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[102]  Jae Won Lee,et al.  pH-responsive polymeric micelle based on PEG-poly(β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[103]  P. Wolf,et al.  Depressive Symptoms and Risk of Stroke: The Framingham Study , 2007, Stroke.

[104]  S. Nagahiro,et al.  Edaravone, a Free Radical Scavenger, Inhibits MMP-9–Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator , 2009, Stroke.

[105]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[106]  J. West,et al.  Nano-C60 cytotoxicity is due to lipid peroxidation. , 2005, Biomaterials.

[107]  Samuel I Stupp,et al.  Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair , 2011, Proceedings of the National Academy of Sciences.

[108]  Taro Shimizu,et al.  PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[109]  M. V. van Zandvoort,et al.  Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[110]  Xiaojun Zhao,et al.  Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis , 2009, Proceedings of the National Academy of Sciences.

[111]  W. Desmet,et al.  Ultrasound thrombolysis in stent thrombosis , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[112]  M. McPherson,et al.  Rational Molecular Design of Complementary Self-Assembling Peptide Hydrogels , 2012, Advanced healthcare materials.

[113]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[114]  David Schubert,et al.  Cerium and yttrium oxide nanoparticles are neuroprotective. , 2006, Biochemical and biophysical research communications.

[115]  T. Webster,et al.  Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke , 2012, International journal of nanomedicine.

[116]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[117]  Ulrich Dirnagl,et al.  Near-infrared fluorescence imaging with fluorescently labeled albumin: A novel method for non-invasive optical imaging of blood–brain barrier impairment after focal cerebral ischemia in mice , 2009, Journal of Neuroscience Methods.

[118]  M. Stevens,et al.  Novel materials for bone and cartilage regeneration. , 2006, Current opinion in chemical biology.

[119]  P. Langhorne,et al.  Do stroke units save lives? , 1993, The Lancet.

[120]  Jangwook P. Jung,et al.  A self-assembling peptide acting as an immune adjuvant , 2009, Proceedings of the National Academy of Sciences.

[121]  C. K. Shen,et al.  C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. , 1999, Journal of medicinal chemistry.

[122]  B. Siesjö,et al.  Energy metabolism, ion homeostasis, and cell damage in the brain. , 1994, Biochemical Society transactions.

[123]  Shuguang Zhang,et al.  Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. , 2005, Seminars in cancer biology.

[124]  Juewon Kim,et al.  Effects of TAT-conjugated platinum nanoparticles on lifespan of mitochondrial electron transport complex I-deficient Caenorhabditis elegans, nuo-1 , 2010, International journal of nanomedicine.

[125]  Naomi J Halas,et al.  Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. , 2003, Annual review of biomedical engineering.

[126]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[127]  N. Sims,et al.  Mitochondria, oxidative metabolism and cell death in stroke. , 2010, Biochimica et biophysica acta.

[128]  J. Saver Time Is Brain—Quantified , 2006, Stroke.

[129]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[130]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[131]  Beverly A Rzigalinski,et al.  Treatment of Neurodegenerative Disorders with Radical Nanomedicine , 2007, Annals of the New York Academy of Sciences.

[132]  P. Lipton,et al.  Ischemic cell death in brain neurons. , 1999, Physiological reviews.

[133]  K. Hynynen,et al.  Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[134]  S. Ricci,et al.  Sonothrombolysis for acute ischaemic stroke. , 2012, The Cochrane database of systematic reviews.

[135]  Lauren M. Graham,et al.  Experimental considerations on the cytotoxicity of nanoparticles. , 2011, Nanomedicine.

[136]  A. Thrift,et al.  Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit? , 2005, Cerebrovascular Diseases.

[137]  A. Schroit,et al.  In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. , 1985, The Journal of biological chemistry.

[138]  Michael G. Fehlings,et al.  Self-Assembling Nanofibers Inhibit Glial Scar Formation and Promote Axon Elongation after Spinal Cord Injury , 2008, The Journal of Neuroscience.

[139]  Shelton D Caruthers,et al.  Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.

[140]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[141]  M. Zakhary,et al.  Oxidative stress in the context of acute cerebrovascular stroke. , 2000, Stroke.

[142]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[143]  Krista L. Niece,et al.  Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers , 2004, Science.

[144]  Shelton D Caruthers,et al.  Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[145]  Alok Dhawan,et al.  Toxicity assessment of nanomaterials: methods and challenges , 2010, Analytical and bioanalytical chemistry.

[146]  Fan Yang,et al.  Robust cell migration and neuronal growth on pristine carbon nanotube sheets and yarns , 2007, Journal of biomaterials science. Polymer edition.

[147]  Mary G. George,et al.  An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[148]  A. Kabanov,et al.  Novel Nanomaterials for Clinical Neuroscience , 2008, Journal of Neuroimmune Pharmacology.

[149]  T. Ishida,et al.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.

[150]  M. Moskowitz,et al.  Synergistic effects of caspase inhibitors and MK‐801 in brain injury after transient focal cerebral ischaemia in mice , 1998, British journal of pharmacology.

[151]  R. Daneman,et al.  The blood–brain barrier in health and disease , 2012, Annals of neurology.

[152]  M. Sasaki,et al.  11C-methionine uptake in cerebrovascular disease: A comparison with18F-FDG PET and99mTc-HMPAO SPECT , 2002, Annals of nuclear medicine.

[153]  V. Labhasetwar,et al.  Optical imaging to map blood-brain barrier leakage , 2013, Scientific Reports.

[154]  Dennis E Discher,et al.  Polymersome carriers: from self-assembly to siRNA and protein therapeutics. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[155]  Konstantin Sokolov,et al.  Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques. , 2009, Nano letters.

[156]  H. Hong,et al.  A new role of substance P as an injury-inducible messenger for mobilization of CD29+ stromal-like cells , 2009, Nature Medicine.

[157]  Maurizio Prato,et al.  Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. , 2013, Angewandte Chemie.

[158]  V. Ona,et al.  Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction , 2001, Neurosurgery.

[159]  Xiaojun Zhao,et al.  Hemostatic efficacy of biological self-assembling peptide nanofibers in a rat kidney model. , 2010, Macromolecular bioscience.

[160]  D. Harman Free radical theory of aging. , 2003, Mutation research.

[161]  Patrick Couvreur,et al.  A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection , 2009, The Journal of Neuroscience.

[162]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[163]  G. Ligresti,et al.  Extracellular Matrix: A Matter of Life and Death , 2008, Connective tissue research.

[164]  D D Allen,et al.  Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.

[165]  M. Moskowitz,et al.  Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[166]  G. Schneider,et al.  Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[167]  A. Kabanov,et al.  Effect of Pluronic P85 on Amino Acid Transport in Bovine Brain Microvessel Endothelial Cells , 2009, Journal of Neuroimmune Pharmacology.

[168]  Samuel A. Wickline,et al.  Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted Therapeutics , 2009, Annals of Biomedical Engineering.

[169]  Z. Fayad,et al.  Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. , 2008, Contrast media & molecular imaging.

[170]  S. Stirdivant,et al.  Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[171]  Kwok-Fai So,et al.  Nano hemostat solution: immediate hemostasis at the nanoscale. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[172]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[173]  R. Whitby,et al.  In Vitro Biocompatibility of Multiwalled Carbon Nanotubes with Sensory Neurons , 2013, Advanced healthcare materials.

[174]  Ming Yan,et al.  An in vitro study of vascular endothelial toxicity of CdTe quantum dots. , 2011, Toxicology.

[175]  M A Horton,et al.  The alpha v beta 3 integrin "vitronectin receptor". , 1997, The international journal of biochemistry & cell biology.

[176]  Patrick Winter,et al.  Nanomedicine Opportunities in Cardiology , 2006, Annals of the New York Academy of Sciences.

[177]  R. Nitschke,et al.  Quantum dots versus organic dyes as fluorescent labels , 2008, Nature Methods.

[178]  J. Koistinaho,et al.  Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1 , 2001, The Journal of Immunology.

[179]  G. Keren,et al.  Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease. , 2006, The American journal of cardiology.

[180]  N. Noordhoek,et al.  Contrast-Enhanced Angiographic Cone-Beam CT of Cerebrovascular Stents: Experimental Optimization and Clinical Application , 2010, American Journal of Neuroradiology.

[181]  O. Salata,et al.  Applications of nanoparticles in biology and medicine , 2004, Journal of nanobiotechnology.

[182]  T Sakthivel,et al.  DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers. , 2000, International journal of pharmaceutics.